Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hanchuan Zupa Granule
- Development stage
- Phase 4
- Lead developer
- Xinjiang Uygur Pharmaceutical
- Administration
- Oral
01
Overview
Hanchuan Zupa Granule is a traditional Uyghur medicine (TUM) primarily indicated for the treatment of chronic airway diseases, including bronchial asthma, chronic obstructive pulmonary disease (COPD), and post-infectious cough. Developed and manufactured by companies such as Xinjiang Yinduolan Uighur Medicine and Xinqikang Pharmaceutical, the formulation is a multi-component herbal medicine. Research indicates that Hanchuan Zupa Granule exerts its therapeutic effects by inhibiting the TLR4-JNK/P38-NF-κB signaling pathway and the subsequent activation of the NLRP3 inflammasome, thereby reducing airway inflammation and mucus hypersecretion. It is currently marketed in China and is frequently evaluated as an adjunctive therapy to standard treatments for asthma control.
- Brand names
- Hanchuan Zupa GranuleLuo-Ou-Ke Zu-Pa
- Other names
- Hanchuan Zupa KeliHan Chuan Zupa granule寒喘祖帕颗粒
02
Targets
CCL2 (C-C motif chemokine 2)IL1R1 (Interleukin-1 Receptor Type 1)JNK (Mitogen-activated protein kinase kinase kinase family)NF-κBNLRP3 (Nod-like receptor family pyrin domain-containing protein 3)TLR4 (Toll-like receptor 4)RK (Ribokinase)MAPK14 (p38 mitogen-activated protein kinase alpha)
Beyond the preview
Go deeper on Hanchuan Zupa Granule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hanchuan Zupa Granule.